Terms ending in 2029
Every in-force patent on Irm LLC's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,507,488 | Fused Nitrogen Containing Heterocycles and Compositions Thereof as Kinase Inhibitors In force · High confidence | Novartis AG | In force | High confidence | |
| US 8,178,563 | Compounds and Compositions as Hedgehog Pathway Modulators In force · High confidence | Sun Pharmaceutical Industries Limited | In force | High confidence | |
| US 8,552,002 | Compounds and Compositions as Protein Kinase Inhibitors In force · High confidence | Novartis AG | In force | High confidence | |
| US 9,216,964 | Hedgehog Pathway Modulators In force · High confidence | Novartis AG | In force | High confidence | |
| US 8,507,491 | Compounds and Compositions as Hedgehog Pathway Inhibitors In force · High confidence | Novartis AG | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Irm LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.